Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Toshiaki Sai"'
Autor:
Shogo Shigeta, Muneaki Shimada, Keita Tsuji, Zen Watanabe, Yasuhito Tanase, Koji Matsuo, Toru Nakanishi, Toshiaki Saito, Daisuke Aoki, Mikio Mikami
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The 2018 International Federation of Gynecology and Obstetrics (FIGO) revision to the staging criteria for uterine cervical cancer adopted pathological staging for patients who underwent surgery. We investigated the correlation between clini
Externí odkaz:
https://doaj.org/article/0ce52f75780d4e3bbbc034a65e603f54
Autor:
Youichiro Ohno, Masaharu Kasai, Masayuki Sano, Tohru Kobayashi, Yoshihiro Matsuno, Kensei Tobinai, Toshiaki Sai, Naoki Ishizuka, Tomomitsu Hotta, Chikara Mikuni, Yasufumi Masaki, Michinori Ogura, Masao Tomonaga, Shigeru Shirakawa, Takenaka T, Hironobu Toki, Tomohiro Kinoshita, Masanori Shimoyama, Tomoko Ohtsu
Publikováno v:
International Journal of Hematology. 80:341-350
The effect of enhancing the dose intensity (DI) of the key drugs in multidrug combination chemotherapy for malignant lymphoma is uncertain. We investigated the survival benefit of dose-intensified multidrug combination chemotherapy for intermediate-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8078d54d0bdde4fae22a08d9ad6e9b59
https://doi.org/10.1532/ijh97.04085
https://doi.org/10.1532/ijh97.04085
Autor:
Masafumi Abe, Tetsuo Kuze, Yuko Hashimoto, Takanori Kawaguchi, Hideo Sakuma, Naoya Nakamura, Yoko Hara, Kazuei Ogawa, Kazuo Watanabe, Shin Matsuda, Shigeyuki Asano, Toshiaki Sai
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 41:73-80
In this study, we reported five cases of CD5+ diffuse large B-cell lymphoma (DLBCL) which initially presented as bone marrow involvement without lymphadenopathy. The cases involved two males and three females, with an average age of 73.8 years. The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3de0a265bf7f846cf11bff799b8caedd
https://doi.org/10.3960/jslrt.41.73
https://doi.org/10.3960/jslrt.41.73
Autor:
Akio Tawara, Yoshiki Sugai, Toshiaki Sai, Masaharu Takahashi, Hiroaki Okamoto, Junichi Kishimoto, Tsutomu Nishizawa
Publikováno v:
Biochemical and Biophysical Research Communications. 279:700-707
Although replicative forms of TT virus (TTV) DNA have been found in the liver and bone marrow cells, mRNAs of TTV have not yet been detected in these tissues. The entire nucleotide sequence of a TTV clone [TYM9 (3759 bases)] isolated from a patient w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52469556914290e9c252616edd81c986
https://doi.org/10.1006/bbrc.2000.4012
https://doi.org/10.1006/bbrc.2000.4012
Autor:
Akio Tawara, Yoshiki Sugai, Tsutomu Nishizawa, Masaharu Takahashi, Takeshi Tanaka, Toshiaki Sai, Fumio Tsuda, Hiroaki Okamoto
Publikováno v:
Biochemical and Biophysical Research Communications. 270:657-662
TT virus (TTV) is a human virus consisting of a single-stranded, circular DNA genome of 3.8 kilobases (kb). To examine whether TTV replicates in peripheral blood mononuclear cells (PBMCs) and bone marrow cells (BMCs), DNA was extracted from the PBMCs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634d4743d284496205cfd6c48d0a700b
https://doi.org/10.1006/bbrc.2000.2481
https://doi.org/10.1006/bbrc.2000.2481
Autor:
Hiroshi Konishi, Toshiaki Sai, Hironobu Toki, Yoshinori Shimamoto, Kinuko Tajima, Satoshi Inaba, Haruhiko Fukuda, Koichi Araki, Akira B. Miura, Masanori Shimoyama, Yoh-ichiro Ohno, Michito Ichimaru, Chikara Mikuni, Masami Hirano, Takenaka T, Shigeru Shirakawa, Shuichi Hanada, Miyuki Niimi
Publikováno v:
Japanese Journal of Clinical Oncology. 29:485-489
Group (JCOG). Results: Eighty-one previously untreated patients were enrolled in the study. For 69 eligible patients, the response rate was 50.7% [95% confidence interval (CI) 38.4-63.0%]. The median survival time was 38.5 (95% CI 32.0-44.4) months.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd9e7e65b7f4661131f4807876ade82c
https://doi.org/10.1093/jjco/29.10.485
https://doi.org/10.1093/jjco/29.10.485
Autor:
Kinuko Tajima, Masanori Shimoyama, Tohru Kobayashi, Toshiaki Sai, Atsushi Oyama, Tomomitsu Hotta, Koichi Araki, Shiro Fukuhara, Hironobu Toki, Miyuki Niimi, Shigeru Shirakawa, Naohito Yamaguchi, Makoto Matsumoto, Kijo Deura, Isao Aoki, Haruhiko Fukuda, Mitsuo Kozuru, Masami Nagai, Kensei Tobinai, Tatsuo Abe, Chikara Mikuni, Susumu Konda
Publikováno v:
Japanese Journal of Clinical Oncology. 29:340-348
Background Patients with acute lymphocytic leukemia (ALL) and those with lymphoblastic lymphoma (LBL) have overlapping clinical and immunophenotypic features and they have been treated with the same or very similar chemotherapy regimens. The goal of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8595323e81d1ae3ac7ed4cf1c28cc8c
https://doi.org/10.1093/jjco/29.7.340
https://doi.org/10.1093/jjco/29.7.340
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 3 (2022)
Externí odkaz:
https://doaj.org/article/f7a5e84412b848dfa9da627e21d8e87b
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 45(5)
A 51-year-old woman was admitted to our hospital with a diagnosis of acute myeloid leukemia (M1) in January 2002. During the course of induction therapy, she developed a fever and chest radiography revealed bilateral infiltrates. She was treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27ab668d2c37990cfeb12bd1f5a4f181
https://pubmed.ncbi.nlm.nih.gov/15199748
https://pubmed.ncbi.nlm.nih.gov/15199748
Autor:
Takeaki Takenaka, Kuniaki Itoh, Takayo Suzuki, Atae Utsunomiya, Shin Matsuda, Takaaki Chou, Toshiaki Sai, Masayuki Sano, Susumu Konda, Tatsuji Ohno, Chikara Mikuni, Kijoh Deura, Takashi Yamada, Fumi Mizorogi, Haruhisa Nagoshi, Masao Tomonaga, Tomomitsu Hotta, Kohichi Kawano, Keitaro Tsushita, Masami Hirano, Masanori Shimoyama, Lymphoma Study Group
Publikováno v:
International journal of hematology. 79(2)
To investigate whether combination chemotherapy with vincristine, cyclophosphamide, prednisolone, and melphalan (COP/ MP) with the addition of ranimustine (MCNU) (MCNU-COP/MP) is superior to the slightly modified COP/MP (mCOP/MP) regimen in multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de0c4a4ba850d08a679a44162e70e332
https://pubmed.ncbi.nlm.nih.gov/15005346
https://pubmed.ncbi.nlm.nih.gov/15005346